Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Medicine (Baltimore) ; 100(35): e26878, 2021 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-34477121

RESUMEN

ABSTRACT: Many free radicles are implicated to activate a number of oncogenic signaling, cause damage to deoxyribonucleic acid and tumor suppressor genes, or promote expression of proto-oncogenes. Reduced level of antioxidants and increases oxidative stress markers are associated with the development of various types of cancer.This prospective study included 60 women who were grouped into equal groups. Patients group included 30 breast cancer women and control group consisting of 30 apparently healthy women. Both groups were compared regarding the serum levels of antioxidants biomarkers (vitamin C, ceruloplasmin, glutathione) and oxidative stress biomarkers, malondialdehyde (MDA), peroxynitrite, and gamma-glutamyl transferase.In regard to the antioxidant biomarkers, there was a significant difference between the patients and the controls regarding the levels of serum ceruloplasmin and glutathione, (P values .000) for each while vitamin C showed no significant correlation (P value .053), while regarding oxidative stress biomarkers, the correlation was significant for both peroxynitrite and MDA (P value .000 and .001) respectively, and not significant for gamma-glutamyl transferase (P value 1.00).Reduced level both ceruloplasmin and glutathione is seen in patients with breast cancer while vitamin C is not associated. Elevated levels of both peroxynitrite and MDA is seen in patients with breast cancer which may be used as serum markers for the early detection of breast cancer.


Asunto(s)
Antioxidantes/análisis , Neoplasias de la Mama/tratamiento farmacológico , Adulto , Antioxidantes/uso terapéutico , Estudios de Casos y Controles , Correlación de Datos , Femenino , Humanos , Persona de Mediana Edad , Estrés Oxidativo , Estudios Prospectivos
2.
Chembiochem ; 16(11): 1670-9, 2015 Jul 27.
Artículo en Inglés | MEDLINE | ID: mdl-25999128

RESUMEN

Chloramphenicol acetyltransferase I (CATI) detoxifies the antibiotic chloramphenicol and confers a corresponding resistance to bacteria. In this study we identified this enzyme as a steroid acetyltransferase and designed a new and efficient Escherichia-coli-based biocatalyst for the regioselective acetylation of C21 hydroxy groups in steroids of pharmaceutical interest. The cells carried a recombinant catI gene controlled by a constitutive promoter. The capacity of the whole-cell system to modify different hydroxysteroids was investigated, and NMR spectroscopy revealed that all substrates were selectively transformed into the corresponding 21-acetoxy derivatives. The biotransformation was optimized, and the reaction mechanism is discussed on the basis of a computationally modeled substrate docking into the crystal structure of CATI.


Asunto(s)
Cloranfenicol O-Acetiltransferasa/metabolismo , Escherichia coli/enzimología , Hidroxiesteroides/química , Hidroxiesteroides/metabolismo , Acetilación , Biocatálisis , Biotransformación , Cloranfenicol/metabolismo , Cloranfenicol O-Acetiltransferasa/química , Glucosa/farmacología , Simulación del Acoplamiento Molecular , Conformación Proteica , Estereoisomerismo , Especificidad por Sustrato
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA